These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 4751587

  • 1. [Hyponatremia syndrome in congestive heart failure].
    Nitter-Hauge S, Brodwall EK, Rootwelt K.
    Tidsskr Nor Laegeforen; 1973 May 10; 93(13):916-9. PubMed ID: 4751587
    [No Abstract] [Full Text] [Related]

  • 2. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B, Cybulski J, Chamiec T.
    Pol Merkur Lekarski; 2000 Aug 10; 9(50):519-21. PubMed ID: 11081314
    [Abstract] [Full Text] [Related]

  • 3. Furosemide and spironolactone doses and hyponatremia in patients with heart failure.
    Velat I, Bušić Ž, Jurić Paić M, Čulić V.
    BMC Pharmacol Toxicol; 2020 Aug 03; 21(1):57. PubMed ID: 32746925
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of cardiac patients with furosemide. Effect on hemodynamics, water and electrolyte balance].
    Sidorenko BA.
    Munch Med Wochenschr; 1969 Oct 03; 111(40):2032-7. PubMed ID: 5394863
    [No Abstract] [Full Text] [Related]

  • 5. [Hyponatremia].
    Hernández R, Madero M.
    Rev Invest Clin; 2013 Oct 03; 65(1):74-87. PubMed ID: 23745446
    [No Abstract] [Full Text] [Related]

  • 6. The effect of aldosterone on sodium and potassium metabolism in congestive cardiac failure.
    Peltola P.
    Ann Clin Res; 1969 Dec 03; 1(4):286-90. PubMed ID: 5371915
    [No Abstract] [Full Text] [Related]

  • 7. [Hyponatremia induced by captopril in patients with congestive cardiac insufficiency. A report of 2 cases].
    Vitola D, Bittar AE, Junges F, dos Santos AA, Rodrigues R.
    Arq Bras Cardiol; 1988 Dec 03; 51(6):463-5. PubMed ID: 3076356
    [No Abstract] [Full Text] [Related]

  • 8. [A little less sodium is not without hazard].
    van Furth WR, Eelkman Rooda SJ.
    Ned Tijdschr Geneeskd; 1993 Jan 09; 137(2):57-60. PubMed ID: 8421527
    [No Abstract] [Full Text] [Related]

  • 9. [Disorders of water-electrolyte metabolism associated with decompensated cirrhosis. The danger of various therapeutic drugs].
    Bodin F, Liguory C, Capelle P, Conte M.
    Sem Hop; 1968 May 14; 44(23):1591-8. PubMed ID: 4302321
    [No Abstract] [Full Text] [Related]

  • 10. [Depletion therapy of chronic congestive heart failure].
    Sánchez A.
    Rev Esp Cardiol; 1968 Apr 14; 21(2):234-73. PubMed ID: 4905456
    [No Abstract] [Full Text] [Related]

  • 11. A correctable complication of advanced congestive heart failure.
    Valle GA, Lemberg L.
    Heart Lung; 1987 Mar 14; 16(2):224-6. PubMed ID: 3546209
    [Abstract] [Full Text] [Related]

  • 12. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F, Blei AT, Blendis LM, Thuluvath PJ.
    Hepatology; 2003 Jan 14; 37(1):182-91. PubMed ID: 12500203
    [Abstract] [Full Text] [Related]

  • 13. [Water-sodium depletion and clonidine in severe arterial hypertension].
    Sobel A, Safar M, Milliez P.
    Maroc Med; 1972 Apr 14; 52(556):187-92. PubMed ID: 5042074
    [No Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of diuretics in congestive heart failure. A detailed study in four patients.
    Mahabir RN, Laufer ST.
    Arch Intern Med; 1969 Jul 14; 124(1):1-7. PubMed ID: 5791481
    [No Abstract] [Full Text] [Related]

  • 15. Management of intractable heart failure with hyponatremia.
    Datey KK, Bhagat SJ, Barat AK, Surana MC.
    Indian J Chest Dis Allied Sci; 1978 Jan 14; 20(1):21-7. PubMed ID: 680867
    [No Abstract] [Full Text] [Related]

  • 16. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 14; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 17. [Intolerance to spironolactone in refractory cardiac insufficiency. Probable changes in the aldosterone receptors. Study of 11 cases].
    Sänchez Torres G, Posadas C, Boyer JL, Guzmán Lara J, Serrano P.
    Arch Inst Cardiol Mex; 1981 Dec 14; 51(3):233-40. PubMed ID: 6456707
    [No Abstract] [Full Text] [Related]

  • 18. Lasix.
    Med Lett Drugs Ther; 1967 Jan 27; 9(2):6-8. PubMed ID: 6032221
    [No Abstract] [Full Text] [Related]

  • 19. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
    Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, Orlandi C, Tolvaptan Investigators.
    Circulation; 2003 Jun 03; 107(21):2690-6. PubMed ID: 12742979
    [Abstract] [Full Text] [Related]

  • 20. Refractory heart failure.
    Magidson O.
    Geriatrics; 1967 May 03; 22(5):132-40. PubMed ID: 6024097
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.